rs7699

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006308.3(HSPB3):​c.282G>A​(p.Leu94Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.576 in 1,613,562 control chromosomes in the GnomAD database, including 271,020 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 22442 hom., cov: 30)
Exomes 𝑓: 0.58 ( 248578 hom. )

Consequence

HSPB3
NM_006308.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.532

Publications

20 publications found
Variant links:
Genes affected
HSPB3 (HGNC:5248): (heat shock protein family B (small) member 3) This gene encodes a muscle-specific small heat shock protein. A mutation in this gene is the cause of autosomal dominant distal hereditary motor neuropathy type 2C.[provided by RefSeq, Sep 2010]
HSPB3 Gene-Disease associations (from GenCC):
  • distal hereditary motor neuropathy type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neuronopathy, distal hereditary motor, type 2C
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 5-54456071-G-A is Benign according to our data. Variant chr5-54456071-G-A is described in ClinVar as Benign. ClinVar VariationId is 353899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.532 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSPB3NM_006308.3 linkc.282G>A p.Leu94Leu synonymous_variant Exon 1 of 1 ENST00000302005.3 NP_006299.1 Q12988Q6ICS9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSPB3ENST00000302005.3 linkc.282G>A p.Leu94Leu synonymous_variant Exon 1 of 1 6 NM_006308.3 ENSP00000303394.1 Q12988

Frequencies

GnomAD3 genomes
AF:
0.537
AC:
81554
AN:
151744
Hom.:
22437
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.444
Gnomad AMI
AF:
0.715
Gnomad AMR
AF:
0.475
Gnomad ASJ
AF:
0.605
Gnomad EAS
AF:
0.355
Gnomad SAS
AF:
0.553
Gnomad FIN
AF:
0.613
Gnomad MID
AF:
0.659
Gnomad NFE
AF:
0.602
Gnomad OTH
AF:
0.551
GnomAD2 exomes
AF:
0.552
AC:
138678
AN:
251306
AF XY:
0.560
show subpopulations
Gnomad AFR exome
AF:
0.449
Gnomad AMR exome
AF:
0.460
Gnomad ASJ exome
AF:
0.607
Gnomad EAS exome
AF:
0.352
Gnomad FIN exome
AF:
0.614
Gnomad NFE exome
AF:
0.607
Gnomad OTH exome
AF:
0.591
GnomAD4 exome
AF:
0.580
AC:
848070
AN:
1461700
Hom.:
248578
Cov.:
62
AF XY:
0.581
AC XY:
422144
AN XY:
727168
show subpopulations
African (AFR)
AF:
0.445
AC:
14914
AN:
33478
American (AMR)
AF:
0.459
AC:
20536
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.602
AC:
15721
AN:
26134
East Asian (EAS)
AF:
0.345
AC:
13680
AN:
39700
South Asian (SAS)
AF:
0.554
AC:
47763
AN:
86254
European-Finnish (FIN)
AF:
0.616
AC:
32887
AN:
53418
Middle Eastern (MID)
AF:
0.679
AC:
3919
AN:
5768
European-Non Finnish (NFE)
AF:
0.597
AC:
663842
AN:
1111834
Other (OTH)
AF:
0.576
AC:
34808
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
24082
48163
72245
96326
120408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17972
35944
53916
71888
89860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.537
AC:
81595
AN:
151862
Hom.:
22442
Cov.:
30
AF XY:
0.534
AC XY:
39611
AN XY:
74196
show subpopulations
African (AFR)
AF:
0.444
AC:
18374
AN:
41408
American (AMR)
AF:
0.475
AC:
7250
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.605
AC:
2097
AN:
3464
East Asian (EAS)
AF:
0.355
AC:
1822
AN:
5134
South Asian (SAS)
AF:
0.553
AC:
2654
AN:
4796
European-Finnish (FIN)
AF:
0.613
AC:
6471
AN:
10556
Middle Eastern (MID)
AF:
0.644
AC:
188
AN:
292
European-Non Finnish (NFE)
AF:
0.602
AC:
40921
AN:
67930
Other (OTH)
AF:
0.555
AC:
1166
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1879
3758
5636
7515
9394
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.568
Hom.:
53369
Bravo
AF:
0.525
Asia WGS
AF:
0.455
AC:
1579
AN:
3478
EpiCase
AF:
0.606
EpiControl
AF:
0.613

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Neuronopathy, distal hereditary motor, type 2C Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:3
Nov 16, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
11
DANN
Benign
0.79
PhyloP100
0.53
PromoterAI
-0.076
Neutral
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7699; hg19: chr5-53751901; COSMIC: COSV57356747; API